Literature DB >> 25359356

An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease.

Sally J Singh1, Milo A Puhan2, Vasileios Andrianopoulos2, Nidia A Hernandes2, Katy E Mitchell2, Catherine J Hill2, Annemarie L Lee2, Carlos Augusto Camillo2, Thierry Troosters2, Martijn A Spruit2, Brian W Carlin2, Jack Wanger2, Véronique Pepin2, Didier Saey2, Fabio Pitta2, David A Kaminsky2, Meredith C McCormack2, Neil MacIntyre2, Bruce H Culver2, Frank C Sciurba2, Susan M Revill2, Veronica Delafosse2, Anne E Holland2.   

Abstract

This systematic review examined the measurement properties of the 6-min walk test (6MWT), incremental shuttle walk test (ISWT) and endurance shuttle walk test (ESWT) in adults with chronic respiratory disease. Studies that report the evaluation or use of the 6MWT, ISWT or ESWT were included. We searched electronic databases for studies published between January 2000 and September 2013. The 6-min walking distance (6MWD) is a reliable measure (intra-class correlation coefficients ranged from 0.82 to 0.99 in seven studies). There is a learning effect, with greater distance walked on the second test (pooled mean improvement of 26 m in 13 studies). Reliability was similar for ISWT and ESWT, with a learning effect also evident for ISWT (pooled mean improvement of 20 m in six studies). The 6MWD correlates more strongly with peak work capacity (r=0.59-0.93) and physical activity (r=0.40-0.85) than with respiratory function (r=0.10-0.59). Methodological factors affecting 6MWD include track length, encouragement, supplemental oxygen and walking aids. Supplemental oxygen also affects ISWT and ESWT performance. Responsiveness was moderate to high for all tests, with greater responsiveness to interventions that included exercise training. The findings of this review demonstrate that the 6MWT, ISWT and ESWT are robust tests of functional exercise capacity in adults with chronic respiratory disease. ©ERS 2014.

Entities:  

Mesh:

Year:  2014        PMID: 25359356     DOI: 10.1183/09031936.00150414

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  167 in total

1.  ATS Core Curriculum 2015. Part I: Adult Pulmonary Medicine.

Authors:  Gaëtane C Michaud; Colleen L Channick; Chad R Marion; Robert M Tighe; James A Town; Andrew M Luks; Jeremy B Richards; Sucharita Kher; Prerna Mota; Gina Hong; Natalie E West; Craig Rackley; Luke Neilans; Josanna Rodriguez-Lopez; Hilary DuBrock; Cassie C Kennedy; Diana J Kelm; Carey C Thomson
Journal:  Ann Am Thorac Soc       Date:  2015-09

Review 2.  Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic Modalities.

Authors:  Mathew Suji Eapen; Philip M Hansbro; Anna-Karin Larsson-Callerfelt; Mohit K Jolly; Stephen Myers; Pawan Sharma; Bernadette Jones; Md Atiqur Rahman; James Markos; Collin Chia; Josie Larby; Greg Haug; Ashutosh Hardikar; Heinrich C Weber; George Mabeza; Vinicius Cavalheri; Yet H Khor; Christine F McDonald; Sukhwinder Singh Sohal
Journal:  Drugs       Date:  2018-11       Impact factor: 9.546

Review 3.  Current best practice in rehabilitation in interstitial lung disease.

Authors:  Atsuhito Nakazawa; Narelle S Cox; Anne E Holland
Journal:  Ther Adv Respir Dis       Date:  2016-11-15       Impact factor: 4.031

4.  Desaturation during the stair-climbing test for patients who will undergo pulmonary resection: an indicator of postoperative complications.

Authors:  Takahito Nakamura; Noriyoshi Sawabata; Yoshiyuki Susaki; Shigeo Muro
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-06-04

5.  Effect of Exercise and Nutrition Prehabilitation on Functional Capacity in Esophagogastric Cancer Surgery: A Randomized Clinical Trial.

Authors:  Enrico M Minnella; Rashami Awasthi; Sarah-Eve Loiselle; Ramanakumar V Agnihotram; Lorenzo E Ferri; Francesco Carli
Journal:  JAMA Surg       Date:  2018-12-01       Impact factor: 14.766

6.  Exercise capacity and cancer-specific quality of life following curative intent treatment of stage I-IIIA lung cancer.

Authors:  Duc Ha; Andrew L Ries; Peter J Mazzone; Scott M Lippman; Mark M Fuster
Journal:  Support Care Cancer       Date:  2018-02-10       Impact factor: 3.603

Review 7.  Six-Minute Walk Test: Clinical Role, Technique, Coding, and Reimbursement.

Authors:  Priya Agarwala; Steve H Salzman
Journal:  Chest       Date:  2019-11-02       Impact factor: 9.410

8.  The minimal important difference for Glittre-ADL test in patients with chronic obstructive pulmonary disease.

Authors:  Aline Almeida Gulart; Cintia Laura Pereira de Araujo; Anelise Bauer Munari; Karoliny Dos Santos; Manuela Karloh; Betina Gabriele Foscarini; Pedro Dal Lago; Anamaria Fleig Mayer
Journal:  Braz J Phys Ther       Date:  2018-11-20       Impact factor: 3.377

Review 9.  The Utility of Exercise Testing in Patients with Lung Cancer.

Authors:  Duc Ha; Peter J Mazzone; Andrew L Ries; Atul Malhotra; Mark Fuster
Journal:  J Thorac Oncol       Date:  2016-05-05       Impact factor: 15.609

10.  8-Foot-Up-and-Go Test is Associated with Hospitalizations and Mortality in Idiopathic Pulmonary Fibrosis: A Prospective Pilot Study.

Authors:  Baruch Vainshelboim; Mordechai Reuven Kramer; Jonathan Myers; Avraham Unterman; Shimon Izhakian; Jose Oliveira
Journal:  Lung       Date:  2019-01-02       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.